{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:56:26Z","timestamp":1794614186325,"version":"4.9.1"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019497","name":"Indian Institute of Technology Jodhpur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.lfs.2023.122358","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T02:19:11Z","timestamp":1702952351000},"page":"122358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Molecular mechanism of cognitive impairment associated with Parkinson's disease: A stroke perspective"],"prefix":"10.1016","volume":"337","author":[{"given":"Sanju","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajit","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.122358_bb0005","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.lfs.2023.122358_bb0010","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0015","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/nn.4641","article-title":"Dopamine induces soluble \u03b1-synuclein oligomers and nigrostriatal degeneration","volume":"20","author":"Mor","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105453","article-title":"Unveiling the mechanism of platelet dysfunction in Parkinson\u2019s disease: the effect of 6-hydroxydopamine on human blood platelets","volume":"112","author":"Beura","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.lfs.2023.122358_bb0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2023.122358_bb0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1017\/cjn.2018.56","article-title":"Stroke and coronary artery disease are associated with Parkinson\u2019s disease","volume":"45","author":"Li","year":"2018","journal-title":"Can. J. Neurol. Sci. Le J. Can. Des Sci. Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2009.136","article-title":"Parkinson disease and comorbid cerebrovascular disease","volume":"5","author":"Nanhoe-Mahabier","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/med.21965","article-title":"Antiplatelet drugs: potential therapeutic options for the management of neurodegenerative diseases","author":"Beura","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.lfs.2023.122358_bb0050","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/mds.26698","article-title":"Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson\u2019s disease","volume":"31","author":"Malek","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0055","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000310414.85144.ee","article-title":"Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study","volume":"70","author":"Driver","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2023.122358_bb0060","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s12031-020-01524-9","article-title":"Association between stroke and Parkinson\u2019s disease: a meta-analysis","volume":"70","author":"Liu","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0065","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/ern.09.73","article-title":"Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia?","volume":"9","author":"Grau-Olivares","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.lfs.2023.122358_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00401-017-1667-0","article-title":"Ischemic stroke: experimental models and reality","volume":"133","author":"Sommer","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.lfs.2023.122358_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.lfs.2023.122358_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/med.21817","article-title":"Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications","volume":"42","author":"Tuo","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.lfs.2023.122358_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207609","article-title":"Pathophysiology and treatment of stroke: present status and future perspectives","volume":"21","author":"Kuriakose","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0090","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/mds.27002","article-title":"Mild cognitive impairment as a risk factor for Parkinson\u2019s disease dementia","volume":"32","author":"Hoogland","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.parkreldis.2019.04.020","article-title":"Conversion to MCI and dementia in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"65","author":"Saredakis","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mdc3.12391","article-title":"The diagnostic accuracy of Parkinson\u2019s disease mild cognitive impairment battery using the movement disorder society task force criteria","volume":"4","author":"Bezdicek","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.lfs.2023.122358_bb0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mds.24059","article-title":"Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson\u2019s disease with dementia","volume":"27","author":"Barton","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0110","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/mds.25902","article-title":"Comparison of the Movement Disorder Society Parkinson\u2019s disease dementia criteria with neuropsychological testing","volume":"29","author":"Barton","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12883-015-0288-2","article-title":"Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study","volume":"15","author":"Mellon","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0120","article-title":"Cognitive rehabilitation improves ischemic stroke-induced cognitive impairment: role of growth factors","volume":"28","author":"Farokhi-Sisakht","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc."},{"key":"10.1016\/j.lfs.2023.122358_bb0125","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2147\/NDT.S67184","article-title":"Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment","volume":"10","author":"Al-Qazzaz","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.lfs.2023.122358_bb0130","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1161\/STR.0000000000000430","article-title":"Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association\/American Stroke Association","volume":"54","author":"El Husseini","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.lfs.2023.122358_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120011","article-title":"Parkinsonism and cerebrovascular disease","volume":"433","author":"Narasimhan","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0140","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.25564","article-title":"Associations between cerebrovascular risk factors and parkinson disease","volume":"86","author":"Kummer","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40478-022-01327-6","article-title":"Ischemic stroke causes Parkinson\u2019s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein","volume":"10","author":"Lohmann","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.lfs.2023.122358_bb0150","article-title":"Pan, Parkinson\u2019s disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study","volume":"8","author":"Huang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2023.122358_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2009.06.005","article-title":"Risk of stroke in patients with idiopathic Parkinson disease","volume":"16","author":"Becker","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12040312","article-title":"Cardiovascular\/stroke risk stratification in Parkinson\u2019s disease patients using atherosclerosis pathway and artificial intelligence paradigm: a systematic review","volume":"12","author":"Suri","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.lfs.2023.122358_bb0165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-150610","article-title":"Vascular risk factors and cognition in Parkinson\u2019s disease","volume":"51","author":"Pilotto","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2023.122358_bb0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/qjmed\/hcz015","article-title":"Stroke in Parkinson\u2019s disease","volume":"112","author":"Huang","year":"2019","journal-title":"QJM"},{"key":"10.1016\/j.lfs.2023.122358_bb0175","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1177\/0271678X17694186","article-title":"Mechanisms of Parkinson\u2019s disease-related proteins in mediating secondary brain damage after cerebral ischemia","volume":"37","author":"Kim","year":"2017","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.lfs.2023.122358_bb0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.toxrep.2017.03.005","article-title":"Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients","volume":"4","author":"Fern\u00e1ndez","year":"2017","journal-title":"Toxicol. Reports."},{"key":"10.1016\/j.lfs.2023.122358_bb0185","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1161\/STROKEAHA.118.022701","article-title":"Iron status and risk of stroke","volume":"49","author":"Gill","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.lfs.2023.122358_bb0190","first-page":"749","article-title":"A comparative study of the amount of \u03b1-synuclein in ischemic stroke and Parkinson\u2019s disease., Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc","volume":"37","author":"Zhao","year":"2016","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.lfs.2023.122358_bb0195","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1523\/JNEUROSCI.1241-16.2016","article-title":"Poststroke induction of \u03b1-Synuclein mediates ischemic brain damage","volume":"36","author":"Kim","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12974-020-01764-x","article-title":"DJ-1 exerts anti-inflammatory effects and regulates NLRX1-TRAF6 via SHP-1 in stroke","volume":"17","author":"Peng","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2023.122358_bb0205","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4103\/1673-5374.139458","article-title":"The role of DJ-1 in the oxidative stress cell death cascade after stroke","volume":"9","author":"Pantcheva","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0210","doi-asserted-by":"crossref","first-page":"15042","DOI":"10.1073\/pnas.232588799","article-title":"Down-regulation of parkin protein in transient focal cerebral ischemia: a link between stroke and degenerative disease?","volume":"99","author":"Mengesdorf","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.122358_bb0215","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/jnc.12340","article-title":"The Parkinson\u2019s disease-associated gene PINK1 protects neurons from ischemic damage by decreasing mitochondrial translocation of the fission promoter Drp1","volume":"127","author":"Zhao","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2023.122358_bb0220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mds.28863","article-title":"Increased stroke risk in patients with Parkinson\u2019s disease with LRRK2 mutations","volume":"37","author":"Mac\u00edas-Garc\u00eda","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0225","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/npp.2009.126","article-title":"The episodic memory system: neurocircuitry and disorders","volume":"35","author":"Dickerson","year":"2010","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.lfs.2023.122358_bb0230","first-page":"478","article-title":"Memory systems., Wiley Interdiscip. Rev","volume":"1","author":"Eichenbaum","year":"2010","journal-title":"Cognit. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.conb.2015.07.009","article-title":"Memory engram storage and retrieval","volume":"35","author":"Tonegawa","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2023.122358_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S1807-59322011001300002","article-title":"Long-term potentiation and long-term depression: a clinical perspective","volume":"66","author":"Bliss","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.lfs.2023.122358_bb0245","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nn.4505","article-title":"Metabotropic action of postsynaptic kainate receptors triggers hippocampal long-term potentiation","volume":"20","author":"Petrovic","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0250","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1152\/jn.01235.2005","article-title":"Long-term potentiation is mediated by multiple kinase cascades involving CaMKII or either PKA or p42\/44 MAPK in the adult rat dentate gyrus in vitro","volume":"95","author":"Wu","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.lfs.2023.122358_bb0255","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1038\/npp.2014.106","article-title":"Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling","volume":"39","author":"Bollen","year":"2014","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.lfs.2023.122358_bb0260","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s11064-008-9848-9","article-title":"Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways","volume":"34","author":"Nguyen","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0265","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2011.08.051","article-title":"Quantitative estimates of the cytoplasmic, PSD, and NMDAR-bound pools of CaMKII in dendritic spines","volume":"1419","author":"Feng","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0270","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1152\/jn.00526.2011","article-title":"Activity-dependent regulation of synaptic strength by PSD-95 in CA1 neurons","volume":"107","author":"Zhang","year":"2012","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.lfs.2023.122358_bb0275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2014.03.001","article-title":"The molecular and systems biology of memory","volume":"157","author":"Kandel","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2023.122358_bb0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2018.11.012","article-title":"Postsynaptic SNARE proteins: role in synaptic transmission and plasticity","volume":"420","author":"Madrigal","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2023.122358_bb0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuropharm.2012.07.018","article-title":"Matching biochemical and functional efficacies confirm ZIP as a potent competitive inhibitor of PKM\u03b6 in neurons","volume":"64","author":"Yao","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2023.122358_bb0290","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1523\/JNEUROSCI.0223-08.2008","article-title":"PKM zeta maintains late long-term potentiation by N-ethylmaleimide-sensitive factor\/GluR2-dependent trafficking of postsynaptic AMPA receptors","volume":"28","author":"Yao","year":"2008","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0295","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.neuron.2016.01.043","article-title":"NMDA receptor-dependent LTD requires transient synaptic incorporation of Ca2+-permeable AMPARs mediated by AKAP150-anchored PKA and calcineurin","volume":"89","author":"Sanderson","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2023.122358_bb0300","doi-asserted-by":"crossref","first-page":"ra18","DOI":"10.1126\/scisignal.2000451","article-title":"Pin1 and PKMzeta sequentially control dendritic protein synthesis","volume":"3","author":"Westmark","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.lfs.2023.122358_bb0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2017.01.012","article-title":"Dementia in Parkinson\u2019s disease","volume":"374","author":"Hanagasi","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0310","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.nbd.2012.03.029","article-title":"Cognitive impairment and dementia in Parkinson\u2019s disease","volume":"46","author":"Pagonabarraga","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2023.122358_bb0315","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/j.neubiorev.2013.09.008","article-title":"Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson\u2019s disease","volume":"37","author":"Lindenbach","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.lfs.2023.122358_bb0320","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuron.2018.07.028","article-title":"A cortical pathogenic theory of Parkinson\u2019s disease","volume":"99","author":"Foffani","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2023.122358_bb0325","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuropsychologia.2018.05.020","article-title":"Mid-frontal theta activity is diminished during cognitive control in Parkinson\u2019s disease","volume":"117","author":"Singh","year":"2018","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.lfs.2023.122358_bb0330","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-330154","article-title":"Evoked mid-frontal activity predicts cognitive dysfunction in Parkinson\u2019s disease","author":"Singh","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.lfs.2023.122358_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.585584","article-title":"Molecular mechanisms of glutamate toxicity in Parkinson\u2019s disease","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0340","article-title":"Roles of glutamate receptors in Parkinson\u2019s disease","volume":"20","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0345","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1038\/s41598-019-45419-1","article-title":"The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson\u2019s disease patients","volume":"9","author":"Nuzzo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.122358_bb0350","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jnr.24024","article-title":"Stimulation of synaptoneurosome glutamate release by monomeric and fibrillated \u03b1-synuclein","volume":"95","author":"Sarafian","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0355","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1523\/JNEUROSCI.1871-20.2020","article-title":"\u03b1-Synuclein oligomers induce glutamate release from astrocytes and excessive Extrasynaptic NMDAR activity in neurons, thus contributing to synapse loss","volume":"41","author":"Trudler","year":"2021","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0360","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2015.11.023","article-title":"Overexpression of \u03b1-synuclein simultaneously increases glutamate NMDA receptor phosphorylation and reduces glucocerebrosidase activity","volume":"611","author":"Yang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2023.122358_bb0365","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1471-4159.2010.06776.x","article-title":"Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson\u2019s disease","volume":"114","author":"Kobylecki","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2023.122358_bb0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuro.2018.08.008","article-title":"AMPA-induced extracellular Zn (2+) influx into nigral dopaminergic neurons causes movement disorder in rats","volume":"69","author":"Tamano","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.lfs.2023.122358_bb0375","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1073\/pnas.1312701111","article-title":"Parkinson-related LRRK2 mutation R1441C\/G\/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3","volume":"111","author":"Muda","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.122358_bb0380","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/BST20160396","article-title":"Cross-talk between LRRK2 and PKA: implication for Parkinson\u2019s disease?","volume":"45","author":"Greggio","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.lfs.2023.122358_bb0385","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2018.02.013","article-title":"CaMKII inhibition ameliorated levodopa-induced dyskinesia by downregulating tyrosine hydroxylase activity in an experimental model of Parkinson\u2019s disease","volume":"1687","author":"Yang","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0390","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1038\/srep06811","article-title":"Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson\u2019s rats","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.122358_bb0395","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1172\/JCI59426","article-title":"PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking","volume":"122","author":"Porras","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2023.122358_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.05.003","article-title":"Apelin-13 attenuates motor impairments and prevents the changes in synaptic plasticity-related molecules in the striatum of Parkinsonism rats","volume":"117","author":"Haghparast","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.lfs.2023.122358_bb0405","article-title":"Differential changes in postsynaptic density proteins in postmortem Huntington\u2019s disease and Parkinson\u2019s disease human brains","volume":"2014","author":"Fourie","year":"2014","journal-title":"J. Neurodegener. Dis."},{"key":"10.1016\/j.lfs.2023.122358_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063016","article-title":"Calmodulin and its binding proteins in Parkinson\u2019s disease","volume":"22","author":"Bohush","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0415","doi-asserted-by":"crossref","first-page":"E11313","DOI":"10.1073\/pnas.1711926115","article-title":"FKBP12 contributes to \u03b1-synuclein toxicity by regulating the calcineurin-dependent phosphoproteome","volume":"114","author":"Caraveo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.122358_bb0420","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4103\/1673-5374.219031","article-title":"Taking out the garbage: cathepsin D and calcineurin in neurodegeneration","volume":"12","author":"Aufschnaiter","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0425","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aax7119","article-title":"Activation of the Akt1-CREB pathway promotes RNF146 expression to inhibit PARP1-mediated neuronal death","volume":"13","author":"Kim","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.lfs.2023.122358_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136045","article-title":"Nurr1 downregulation is caused by CREB inactivation in a Parkinson\u2019s disease mouse model","volume":"759","author":"Xu","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2023.122358_bb0435","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.05.023","article-title":"Low BDNF is associated with cognitive impairments in patients with Parkinson\u2019s disease","volume":"29","author":"Wang","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010257","article-title":"Regulation of BDNF-TrkB signaling and potential therapeutic strategies for Parkinson\u2019s disease","volume":"9","author":"Jin","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2023.122358_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031170","article-title":"BDNF as a promising therapeutic agent in Parkinson\u2019s disease","volume":"21","author":"Palasz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0450","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/pmic.201400069","article-title":"Differential expression of synaptic proteins in unilateral 6-OHDA lesioned rat model-a comparative proteomics approach","volume":"14","author":"Xiong","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.lfs.2023.122358_bb0455","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210091","article-title":"Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders","volume":"11","author":"Cuttler","year":"2021","journal-title":"Open Biol."},{"key":"10.1016\/j.lfs.2023.122358_bb0460","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.15252\/embj.201695773","article-title":"The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals","volume":"36","author":"Vanhauwaert","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2023.122358_bb0465","doi-asserted-by":"crossref","first-page":"12428","DOI":"10.1073\/pnas.2004335117","article-title":"Absence of Sac2\/INPP5F enhances the phenotype of a Parkinson\u2019s disease mutation of synaptojanin 1","volume":"117","author":"Cao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.122358_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105326","article-title":"Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson\u2019s disease","volume":"154","author":"Zou","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2023.122358_bb0475","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00401-018-1892-1","article-title":"Synapsin III deficiency hampers \u03b1-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson\u2019s disease","volume":"136","author":"Faustini","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.lfs.2023.122358_bb0480","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.ymthe.2022.01.021","article-title":"Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson\u2019s disease-like phenotype","volume":"30","author":"Faustini","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2023.122358_bb0485","first-page":"185","article-title":"Expression of synaptophysin protein in different dopaminergic cell lines","volume":"2","author":"Bai","year":"2014","journal-title":"J. Biochem. Pharmacol. Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0490","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4196\/kjpp.2017.21.6.625","article-title":"MPTP-induced vulnerability of dopamine neurons in A53T \u03b1-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation","volume":"21","author":"Lee","year":"2017","journal-title":"Korean J. Physiol. Pharmacol. Off. J. Korean Physiol. Soc. Korean Soc. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122358_bb0495","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41467-017-02593-y","article-title":"Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson\u2019s disease-like pathology","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2023.122358_bb0500","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/glia.23186","article-title":"Synaptotagmin-11 inhibits cytokine secretion and phagocytosis in microglia","volume":"65","author":"Du","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2023.122358_bb0505","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0510","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jalz.2018.06.3061","article-title":"Stroke and dementia risk: a systematic review and meta-analysis","volume":"14","author":"Ku\u017ama","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.lfs.2023.122358_bb0515","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","article-title":"Post-stroke dementia - a comprehensive review","volume":"15","author":"Mijajlovi\u0107","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.lfs.2023.122358_bb0520","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","article-title":"Stroke injury, cognitive impairment and vascular dementia","volume":"1862","author":"Kalaria","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2023.122358_bb0525","first-page":"64","article-title":"Plasticity of cortical projections after stroke","volume":"9","author":"Carmichael","year":"2003","journal-title":"Neurosci. a Rev. J. Bringing Neurobiol. Neurol. Psychiatry"},{"key":"10.1016\/j.lfs.2023.122358_bb0530","first-page":"56","article-title":"Cortical reorganization after stroke: how much and how functional?","volume":"20","author":"Grefkes","year":"2014","journal-title":"Neurosci. a Rev. J. Bringing Neurobiol. Neurol. Psychiatry."},{"key":"10.1016\/j.lfs.2023.122358_bb0535","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yexcr.2016.12.028","article-title":"Memantine attenuates cell apoptosis by suppressing the calpain-caspase-3 pathway in an experimental model of ischemic stroke","volume":"351","author":"Chen","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0540","first-page":"14423","article-title":"The receptor-receptor interaction between mGluR1 receptor and NMDA receptor: a potential therapeutic target for protection against ischemic stroke., FASEB J. Off. Publ. Fed. Am. Soc","volume":"33","author":"Lai","year":"2019","journal-title":"Exp. Biol."},{"key":"10.1016\/j.lfs.2023.122358_bb0545","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/jcbfm.2012.124","article-title":"\u03b1CaMKII is differentially regulated in brain regions that exhibit differing sensitivities to ischemia and excitotoxicity","volume":"32","author":"Skelding","year":"2012","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.lfs.2023.122358_bb0550","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuint.2017.01.012","article-title":"The role of Ca (2+)-calmodulin stimulated protein kinase II in ischaemic stroke - a potential target for neuroprotective therapies","volume":"107","author":"Rostas","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2023.122358_bb0555","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1021\/acscentsci.8b00230","article-title":"A friend or foe: calcineurin across the gamut of neurological disorders","volume":"4","author":"Saraf","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0560","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s11064-018-2572-1","article-title":"Neuroprotection of cytisine against cerebral ischemia-reperfusion injury in mice by regulating NR2B-ERK\/CREB signal pathway","volume":"43","author":"Zhao","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0565","doi-asserted-by":"crossref","first-page":"C570","DOI":"10.1152\/ajpcell.00353.2014","article-title":"A neuroprotective role of the NMDA receptor subunit Glu N3A (NR3A) in ischemic stroke of the adult mouse","volume":"308","author":"Lee","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.lfs.2023.122358_bb0570","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13041-018-0357-8","article-title":"Targeting NMDA receptors in stroke: new hope in neuroprotection","volume":"11","author":"Wu","year":"2018","journal-title":"Mol. Brain"},{"key":"10.1016\/j.lfs.2023.122358_bb0575","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.1193785","article-title":"Electrical synapses control hippocampal contributions to fear learning and memory","volume":"331","author":"Bissiere","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.lfs.2023.122358_bb0580","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193510","article-title":"Astroglial connexins and cognition: memory formation or deterioration?","volume":"40","author":"He","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.lfs.2023.122358_bb0585","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3389\/fneur.2020.00703","article-title":"The multifaceted role of astrocyte connexin 43 in ischemic stroke through forming hemichannels and gap junctions","volume":"11","author":"Liang","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0590","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/aps.2015.39","article-title":"Connexin 43 stabilizes astrocytes in a stroke-like milieu to facilitate neuronal recovery","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2023.122358_bb0595","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainresbull.2019.10.006","article-title":"Ginsenoside Rb1 promotes motor functional recovery and axonal regeneration in post-stroke mice through cAMP\/PKA\/CREB signaling pathway","volume":"154","author":"Gao","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2023.122358_bb0600","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainres.2014.06.031","article-title":"HO-1 attenuates hippocampal neurons injury via the activation of BDNF-TrkB-PI3K\/Akt signaling pathway in stroke","volume":"1577","author":"Qi","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0605","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3892\/etm.2021.9850","article-title":"Estrogen administration attenuates post-stroke depression by enhancing CREB\/BDNF\/TrkB signaling in the rat hippocampus","volume":"21","author":"Jiang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2023.122358_bb0610","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10571-019-00709-0","article-title":"Inhibition of reactive astrocytes with fluorocitrate ameliorates learning and memory impairment through upregulating CRTC1 and Synaptophysin in ischemic stroke rats","volume":"39","author":"Zhang","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2023.122358_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112520","article-title":"H(2)S attenuates injury after ischemic stroke by diminishing the assembly of CaMKII with ASK1-MKK3-p38 signaling module","volume":"384","author":"Song","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0620","first-page":"111","article-title":"Variations in immediate-early genes encoding c-Fos, c-Jun and IER5 transcription factors are associated with ischemic stroke","volume":"4","author":"Tadevosyan","year":"2015","journal-title":"Adv. Genet. Eng."},{"key":"10.1016\/j.lfs.2023.122358_bb0625","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1161\/01.STR.26.9.1639","article-title":"Induction of c-fos and c-jun gene products and heat shock protein after brief and prolonged cerebral ischemia in gerbils","volume":"26","author":"Takemoto","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.lfs.2023.122358_bb0630","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7555\/JBR.28.20140033","article-title":"PKM\u03b6 knockdown disrupts post-ischemic long-term potentiation via inhibiting postsynaptic expression of aminomethyl phosphonic acid receptors","volume":"29","author":"Cheng","year":"2015","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0635","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212585","article-title":"PSD-95: an effective target for stroke therapy using neuroprotective peptides","volume":"22","author":"Ugalde-Trivi\u00f1o","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0640","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1161\/01.STR.0000013708.54623.DE","article-title":"Persistent defect in transmitter release and synapsin phosphorylation in cerebral cortex after transient moderate ischemic injury","volume":"33","author":"Bolay","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.lfs.2023.122358_bb0645","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2009.03.047","article-title":"Up-regulation of syntaxin1 in ischemic cortex after permanent focal ischemia in rats","volume":"1272","author":"Cao","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0650","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s40478-019-0866-4","article-title":"Triiodothyronine modulates neuronal plasticity mechanisms to enhance functional outcome after stroke","volume":"7","author":"Talhada","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.lfs.2023.122358_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101681","article-title":"Role of platelet in Parkinson\u2019s disease: insights into pathophysiology & theranostic solutions","volume":"80","author":"Beura","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.lfs.2023.122358_bb0660","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1474-4422(21)00249-0","article-title":"Amantadine in the treatment of Parkinson\u2019s disease and other movement disorders","volume":"20","author":"Rascol","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0665","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.brainresbull.2017.01.024","article-title":"Preventive treatment of astaxanthin provides neuroprotection through suppression of reactive oxygen species and activation of antioxidant defense pathway after stroke in rats","volume":"130","author":"Pan","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2023.122358_bb0670","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1007\/s11064-022-03565-5","article-title":"Dose-dependent effects of Astaxanthin on ischemia\/reperfusion induced brain injury in MCAO model rat","volume":"47","author":"Taheri","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0675","first-page":"135","article-title":"Effects of astaxanthin onaxonal regeneration via cAMP\/PKA signaling pathway in mice with focal cerebral infarction","volume":"23","author":"Wang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0680","article-title":"Astaxanthin attenuates acute cerebral infarction via Nrf-2\/HO-1 pathway in rats","volume":"69","author":"Yang","year":"2021","journal-title":"Curr. Res. Transl. Med."},{"key":"10.1016\/j.lfs.2023.122358_bb0685","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.18632\/oncotarget.23737","article-title":"Astaxanthin is neuroprotective in an aged mouse model of Parkinson\u2019s disease","volume":"9","author":"Grimmig","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2023.122358_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/md19040201","article-title":"Molecular mechanisms of astaxanthin as a potential neurotherapeutic agent","volume":"19","author":"Bahbah","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.lfs.2023.122358_bb0695","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2202-13-156","article-title":"Astaxanthin protects against MPP(+)-induced oxidative stress in PC12 cells via the HO-1\/NOX2 axis","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0700","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/md11041019","article-title":"Astaxanthin suppresses MPP(+)-induced oxidative damage in PC12 cells through a Sp1\/NR1 signaling pathway","volume":"11","author":"Ye","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.lfs.2023.122358_bb0705","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neures.2020.04.003","article-title":"Astaxanthin suppresses endoplasmic reticulum stress and protects against neuron damage in Parkinson\u2019s disease by regulating mi R-7\/SNCA axis","volume":"165","author":"Shen","year":"2021","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0710","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2165\/00003495-200565180-00012","article-title":"Losartan: a review of its use in stroke risk reduction in patients with hypertension and left ventricular hypertrophy","volume":"65","author":"Moen","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2023.122358_bb0715","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.clinthera.2006.06.002","article-title":"Review of the molecular pharmacology of losartan and its possible relevance to stroke prevention in patients with hypertension","volume":"28","author":"D\u00edez","year":"2006","journal-title":"Clin. Ther."},{"key":"10.1016\/j.lfs.2023.122358_bb0720","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/cns.12015","article-title":"The neuroprotective effect of losartan through inhibiting AT1\/ASK1\/MKK4\/JNK3 pathway following cerebral I\/R in rat hippocampal CA1 region","volume":"18","author":"Zhang","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.lfs.2023.122358_bb0725","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresbull.2012.06.010","article-title":"Losartan, an angiotensin II type 1 receptor blocker, ameliorates cerebral ischemia-reperfusion injury via PI3K\/Akt-mediated eNOS phosphorylation","volume":"89","author":"Liu","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2023.122358_bb0730","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/mds.21945","article-title":"A case of parkinsonism worsened by losartan: a probable new adverse effect","volume":"23","author":"Sarma","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0735","article-title":"Neurobehavioral effects of losartan on rotenone induced Parkinsonism in rats","volume":"10","author":"KG","year":"2019","journal-title":"Indian J. Public Heal. Res. Dev."},{"key":"10.1016\/j.lfs.2023.122358_bb0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-2-1","article-title":"Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra","volume":"2","author":"Grammatopoulos","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.lfs.2023.122358_bb0745","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pathophys.2013.10.001","article-title":"Losartan pretreatment reduces neurodegeneration and behavioural symptoms in 6-hydroxydopamine induced unilateral rat model of Parkinson\u2019s disease","volume":"20","author":"Moradganjeh","year":"2013","journal-title":"Pathophysiology"},{"key":"10.1016\/j.lfs.2023.122358_bb0750","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vph.2016.10.006","article-title":"Aspirin, stroke and drug-drug interactions","volume":"87","author":"Russo","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122358_bb0755","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11481-018-9808-3","article-title":"Low-dose aspirin upregulates tyrosine hydroxylase and increases dopamine production in dopaminergic neurons: implications for Parkinson\u2019s disease","volume":"14","author":"Rangasamy","year":"2019","journal-title":"J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol."},{"key":"10.1016\/j.lfs.2023.122358_bb0760","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(03)00170-0","article-title":"Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats","volume":"44","author":"Maharaj","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2023.122358_bb0765","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41582-020-0394-7","article-title":"Aspirin and ibuprofen could lower risk of LRRK2 Parkinson disease","volume":"16","author":"Fyfe","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0770","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1353-8020(02)00022-6","article-title":"Selective destruction of dopaminergic neurons by low concentrations of 6-OHDA and MPP+: protection by acetylsalicylic acid aspirin","volume":"8","author":"Carrasco","year":"2002","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0775","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.3923\/pjbs.2007.3853.3858","article-title":"Effects of aspirin and celecoxib on rigidity in a rat model of Parkinson\u2019s disease","volume":"10","author":"Moghaddam","year":"2007","journal-title":"Pakistan J. Biol. Sci. PJBS."},{"key":"10.1016\/j.lfs.2023.122358_bb0780","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000228709","article-title":"High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART)","volume":"28","author":"Elkind","year":"2009","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.lfs.2023.122358_bb0785","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/mds.28474","article-title":"Randomized, controlled trial of lovastatin in early-stage Parkinson\u2019s disease","volume":"36","author":"Lin","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0790","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2009.11.015","article-title":"Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies","volume":"221","author":"Koob","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.682320","article-title":"Lovastatin alleviates \u03b1-synuclein aggregation and phosphorylation in cellular models of synucleinopathy","volume":"14","author":"Dai","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0800","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1523\/JNEUROSCI.4720-07.2008","article-title":"The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson\u2019s disease","volume":"28","author":"Schuster","year":"2008","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0805","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1570159X17666190927113021","article-title":"Nimodipine reappraised: an old drug with a future","volume":"18","author":"Carlson","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.lfs.2023.122358_bb0810","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/10641960802580232","article-title":"Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies","volume":"30","author":"Tomassoni","year":"2008","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.lfs.2023.122358_bb0815","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jchemneu.2018.02.001","article-title":"Nimodipine attenuates the parkinsonian neurotoxin, MPTP-induced changes in the calcium binding proteins, calpain and calbindin","volume":"95","author":"Singh","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.lfs.2023.122358_bb0820","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(96)00917-1","article-title":"1-Methyl-4-phenyl-1, 2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level","volume":"741","author":"Kupsch","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0825","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.neuropharm.2008.10.016","article-title":"Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation","volume":"56","author":"Li","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2023.122358_bb0830","doi-asserted-by":"crossref","first-page":"13413","DOI":"10.1021\/acs.jmedchem.0c00976","article-title":"Recent advances on nitrones design for stroke treatment","volume":"63","author":"Marco-Contelles","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2023.122358_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113005","article-title":"Tetramethylpyrazine: a review on its mechanisms and functions","volume":"150","author":"Lin","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2023.122358_bb0840","first-page":"1963","article-title":"Tetramethylpyrazine alleviated cytokine synthesis and dopamine deficit and improved motor dysfunction in the mice model of Parkinson\u2019s disease., Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc","volume":"35","author":"Zhao","year":"2014","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.lfs.2023.122358_bb0845","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7150\/ijbs.8366","article-title":"Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson\u2019s disease induced by MPTP","volume":"10","author":"Lu","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2023.122358_bb0850","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1007\/s12035-016-0028-7","article-title":"Tetramethylpyrazine ameliorates rotenone-induced Parkinson\u2019s disease in rats: involvement of its anti-inflammatory and anti-apoptotic actions","volume":"54","author":"Michel","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2023.122358_bb0855","first-page":"229","article-title":"Atorvastatin in stroke: a review of SPARCL and subgroup analysis","volume":"6","author":"Huisa","year":"2010","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.lfs.2023.122358_bb0860","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1517\/14656566.8.16.2789","article-title":"Atorvastatin in prevention of stroke and transient ischaemic attack","volume":"8","author":"Amarenco","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.lfs.2023.122358_bb0865","first-page":"162","article-title":"In vitro 6-hydroxydopamine-induced toxicity in striatal, cerebrocortical and hippocampal slices is attenuated by atorvastatin and MK-801","volume":"37","author":"Massari","year":"2016","journal-title":"Toxicol. Vitr. an Int. J. Publ. Assoc. with BIBRA."},{"key":"10.1016\/j.lfs.2023.122358_bb0870","doi-asserted-by":"crossref","first-page":"831","DOI":"10.18632\/aging.202189","article-title":"Atorvastatin improves motor function, anxiety and depression by NOX2-mediated autophagy and oxidative stress in MPTP-lesioned mice","volume":"13","author":"Yan","year":"2020","journal-title":"Aging (Albany. NY)"},{"key":"10.1016\/j.lfs.2023.122358_bb0875","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2013.03.029","article-title":"Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson\u2019s disease","volume":"1513","author":"Castro","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0880","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s40263-021-00862-5","article-title":"Amantadine revisited: a contender for initial treatment in Parkinson\u2019s disease?","volume":"35","author":"Marmol","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.lfs.2023.122358_bb0885","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12028-020-00977-5","article-title":"Amantadine and modafinil as neurostimulants during post-stroke care: a systematic review","volume":"33","author":"Gagnon","year":"2020","journal-title":"Neurocrit. Care"},{"key":"10.1016\/j.lfs.2023.122358_bb0890","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12028-020-00986-4","article-title":"Amantadine and modafinil as neurostimulants following acute stroke: a retrospective study of intensive care unit patients","volume":"34","author":"Leclerc","year":"2021","journal-title":"Neurocrit. Care"},{"key":"10.1016\/j.lfs.2023.122358_bb0895","first-page":"37","article-title":"Amantadine sulfate (PK-Merz) in the treatment of ischemic stroke: a clinical-experimental study","volume":"109","author":"Khasanova","year":"2009","journal-title":"Zhurnal Nevrol. i Psikhiatrii Im. SS Korsakova."},{"key":"10.1016\/j.lfs.2023.122358_bb0900","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12883-021-02444-w","article-title":"Early amantadine treatment reduces the risk of death in patients with large hemisphere infarctions:a Chinese hospital-based study","volume":"21","author":"Li","year":"2021","journal-title":"BMC Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0905","first-page":"55","article-title":"Amantadine: a review of use in child and adolescent psychiatry","volume":"22","author":"Hosenbocus","year":"2013","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry = J. l\u2019Academie Can. Psychiatr. l\u2019enfant l\u2019adolescent."},{"key":"10.1016\/j.lfs.2023.122358_bb0910","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/brain\/awv104","article-title":"Parkinson\u2019s disease dementia: a neural networks perspective","volume":"138","author":"Gratwicke","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2023.122358_bb0915","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuint.2018.11.007","article-title":"Enhanced AMPA receptor-mediated excitatory transmission in the rodent rostromedial tegmental nucleus following lesion of the nigrostriatal pathway","volume":"122","author":"Chang","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2023.122358_bb0920","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41598-017-00614-w","article-title":"Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson\u2019s disease model","volume":"7","author":"Ham","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.122358_bb0925","first-page":"218","article-title":"Effect of Baicalin on the expression of connexin 36 in the cerebral cortex and striatum area of Parkinson\u2019s disease model rat","volume":"99","author":"Halida","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.lfs.2023.122358_bb0930","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cellsig.2019.03.010","article-title":"The role and therapeutic potential of connexins, pannexins and their channels in Parkinson\u2019s disease","volume":"58","author":"Ahmadian","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2023.122358_bb0935","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-synuclein induced synaptopathy in Parkinson\u2019s disease","volume":"12","author":"Bridi","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0940","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1460-9568.2012.08003.x","article-title":"Ablation of serum response factor in dopaminergic neurons exacerbates susceptibility towards MPTP-induced oxidative stress","volume":"35","author":"Rieker","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.lfs.2023.122358_bb0945","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neuroscience.2017.11.040","article-title":"Serum response factor promotes dopaminergic neuron survival via activation of beclin 1-dependent autophagy","volume":"371","author":"Cheng","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2023.122358_bb0950","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.expneurol.2018.01.009","article-title":"Early activation of Egr-1 promotes neuroinflammation and dopaminergic neurodegeneration in an experimental model of Parkinson\u2019s disease","volume":"302","author":"Yu","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2023.122358_bb0955","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1385\/MN:32:2:145","article-title":"AMPA receptor subunit GluR2 gates injurious signals in ischemic stroke","volume":"32","author":"Soundarapandian","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2023.122358_bb0960","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1568007053544129","article-title":"AMPA receptor antagonists for the treatment of stroke","volume":"4","author":"Weiser","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.lfs.2023.122358_bb0965","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12975-021-00901-9","article-title":"Calcium\/calmodulin-dependent protein kinase II in cerebrovascular diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0970","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainresbull.2014.02.005","article-title":"A neuroproteomic and systems biology analysis of rat brain post intracerebral hemorrhagic stroke","volume":"102","author":"Ren","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2023.122358_bb0975","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0169-328X(00)00237-0","article-title":"Differential expression of neurexin mRNA in CA1 and CA3 hippocampal neurons in response to ischemic insult","volume":"84","author":"Sun","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.lfs.2023.122358_bb0980","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1161\/STROKEAHA.115.009729","article-title":"Role of Neurexin-1\u03b2 and neuroligin-1 in cognitive dysfunction after subarachnoid hemorrhage in rats","volume":"46","author":"Shen","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.lfs.2023.122358_bb0985","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s11064-020-03006-1","article-title":"Attenuation of acute intracerebral hemorrhage-induced microglial activation and neuronal death mediated by the blockade of metabotropic glutamate receptor 5 in vivo","volume":"45","author":"Rahman","year":"2020","journal-title":"Neurochem. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523009931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523009931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:15:12Z","timestamp":1758402912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523009931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":197,"alternative-id":["S0024320523009931"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122358","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanism of cognitive impairment associated with Parkinson's disease: A stroke perspective","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122358"}}